Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis.
Jones
Rachel
R
Department of Nephrology and Department of Infection, Guy's and St Thomas' Hospitals, London, UK.
Shah
Sapna
S
MacMahon
Eithne E M
EE
Goldsmith
David J A
DJ
D000368:Aged; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D009894:Opportunistic Infections / Q000150:complications / Q000209:etiology; D011014:Pneumonia / Q000150:complications / Q000209:etiology*; D018357:Respiratory Syncytial Virus Infections / Q000150:complications / Q000209:etiology*; D016896:Treatment Outcome; D014657:Vasculitis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology
D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents